SRTA · Strata Critical Medical, Inc.
$5.04
-0.05 (-0.98%)
At close · Jul 24
Market Cap
$440.42M
Shares
86.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-03 | 2026-05-28 | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| DEF 14A | 2026-04-14 | 2026-05-28 | |
| Investor Event Transcript | 2026-03-31 | — | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-02-05 | 2026-01-30 | |
| 8-K | 2025-12-03 | 2025-12-02 | |
| 8-K/A | 2025-12-02 | 2025-09-16 | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-09-16 | — | |
| 8-K/A | 2025-09-12 | 2025-05-08 | |
| 8-K | 2025-08-29 | 2025-08-28 | |
| 8-K/A | 2025-08-29 | 2025-08-01 | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-04 | 2025-08-01 | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-03-24 | 2025-05-06 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-03-22 | — | |
| DEF 14A | 2024-03-22 | 2024-05-02 | |
| 8-K | 2024-03-20 | — | |
| 8-K | 2024-03-12 | — | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2023-11-08 | — | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| 8-K | 2023-05-11 | — | |
| 8-K | 2023-05-11 | 2023-05-09 | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| DEF 14A | 2023-03-30 | 2023-05-09 | |
| 8-K | 2023-03-30 | — | |
| 10-K | 2023-03-16 | 2022-12-31 | |
| 8-K | 2023-03-14 | — |
Showing 1–50 of 91 filings
Key facts
CIK
1779128
CUSIP
092667104
13F (30d)
13 filings
13 filers
Visit website
Investor relations